Table 5

Inhibitor eradication and patient survival following immunosuppression

Treatment groupNo. of patients analyzed for inhibitor eradicationNo. of remission events (% of group)Median time to remission, d (95% CI)No. of patients analyzed for survivalNo. of deaths from any cause (% of group)Median time presentation to death from any cause, d (95% CI)
Steroids alone 34 26 (76) 49 (31-62) 38 18 (47) 767 (148-1122) 
Steroids and cytotoxics started together 45 35 (78) 39 (34-57) 48 18 (38) 975 (526-1176) 
Steroids and cytotoxics regardless of order started 81 61 (75) 56 (40-79) 89 37 (42) 870 (526-1176) 
Cytotoxics alone 4 (57) 273* Not defined 
Treatment groupNo. of patients analyzed for inhibitor eradicationNo. of remission events (% of group)Median time to remission, d (95% CI)No. of patients analyzed for survivalNo. of deaths from any cause (% of group)Median time presentation to death from any cause, d (95% CI)
Steroids alone 34 26 (76) 49 (31-62) 38 18 (47) 767 (148-1122) 
Steroids and cytotoxics started together 45 35 (78) 39 (34-57) 48 18 (38) 975 (526-1176) 
Steroids and cytotoxics regardless of order started 81 61 (75) 56 (40-79) 89 37 (42) 870 (526-1176) 
Cytotoxics alone 4 (57) 273* Not defined 

Comparison of patients treated with steroids alone and those treated with steroids and cytotoxics started together at presentation revealed no significant difference for inhibitor eradication or death. Comparison of steroid-treated patients with all patients treated with steroids and cytotoxics, irrespective of the order of starting also did not show any difference for inhibitor eradication or survival.

*

Too few patients to allow valid calculation of confidence intervals.

Close Modal

or Create an Account

Close Modal
Close Modal